AI-Powered Triage Platform Could Aid Future Viral Outbreak Response
A team of researchers from Yale University and other institutions globally has developed an innovative patient triage platform powered by artificial intelligence (AI) that the researchers say is capable of predicting patient disease severity and length of hospitalization during a viral outbreak.
High Exposure to COVID Virus May Reduce Protection From Vaccination and Prior Infection
High levels of exposure to the virus that causes COVID-19 may reduce or overcome the protection that vaccination and prior infection provides, according to a new study by researchers from Yale University, the University of Florida, and the Connecticut Department of Correction.
Research reveals boosting strategies that mitigate risks of COVID-19 in cancer patients
New research led by scientists at Yale University and the University of North Carolina at Charlotte finds that the rate at which additional COVID-19 boosters are needed for cancer patients depends on the treatment they are receiving.
Vaccine politics may be to blame for GOP excess deaths, study finds
The political maelstrom swirling around coronavirus vaccines may be to blame for a higher rate of excess deaths among registered Republicans in Ohio and Florida during the coronavirus pandemic, according to a study published Monday.Source: The Washington Post
Vaccination Has a Lower Risk of Autoantibody Development Than COVID Natural Immunity
Yale researchers report that while both mRNA vaccines and SARS CoV-2 infection build immunity to the virus, they did not see new autoantibodies in those who received the vaccination. This finding contradicts a claim that COVID vaccines trigger autoimmune responses.
For Hurricane Katrina Survivors, COVID-19 Brings a New Mental Health Toll
A new study shows that for some low-income mothers in New Orleans, the COVID-19 pandemic was associated with the same, or worse, mental health impacts as Hurricane Katrina, one of the worst national disasters in U.S. history.
Participant-centric Trial Will Test if Antiviral Paxlovid Can Help With Long COVID
Researchers are still in the dark on the mechanisms underlying and how to treat long COVID. A new clinical trial using the oral antiviral Paxlovid will provide urgently needed insights for COVID long-haulers and their providers.
Annual or Biannual Boosters Are Optimal for Fighting Endemic COVID-19, Study Shows
A team of scientists led by faculty at the Yale School of Public Health and the University of North Carolina at Charlotte finds that updated boosters administered on an annual or biannual basis greatly reduce the long-term risk of infection from endemic COVID-19.
Yale Internal Medicine Faculty Partner with Formerly Incarcerated Leaders to Obtain R01
The COVID-19 pandemic has had a disproportionate impact on many people in underserved communities, including those who are incarcerated or work in our nation’s prison systems. Infections across this community have been five times higher than in the general U.S. population. Surrounding communities have also been disproportionately affected.
COVID Restrictions May Have Contributed to Increase in RSV Infections. But Relief Could Be Coming Soon.
Annual spikes in infections from the respiratory syncytial virus — or RSV — are usually so predictable that “you can set your clock” by it, says Yale School of Public Health Associate Professor of Epidemiology (Microbial Diseases) Daniel Weinberger. Normally a cold-weather epidemic, RSV usually spreads among young children, straining hospitals in the Northern Hemisphere as early as late October and lasting until the cold and flu season wanes in spring. The COVID-19 pandemic appears to have upended this rhythm in one country and possibly others.
Primary series and original booster provide protection against Omicron infection
A study published December 1 in the open-access journal PLOS Medicine by Margaret L. Lind at the Yale School of Public Health and colleagues suggests that the additional protection offered by the original booster shot may be reduced among people with previous COVID-19 infection.
Study Finds Large Gap in Excess Deaths Along Partisan Lines After COVID-19 Vaccines Introduced
A team of Yale researchers has found that Republican voters in two U.S. states had more excess deaths than Democratic voters after vaccines for COVID-19 became widely available to counter the disease. The discrepancy didn’t exist prior to the vaccines.
Will Long COVID Research Provide Answers for Poorly Understood Diseases Like ME/CFS?
ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) is a highly disabling, severe condition that has been largely overlooked and even questioned as an illness by physicians and biomedical researchers for decades. But now, scientists including Yale's Akiko Iwasaki and Harlan Krumholz are finding parallels between post-infection long COVID and ME/CFS.
Yale School of Public Health joins CDC-funded Pathogen Genomics Center of Excellence
The Massachusetts Department of Public Health has selected the Yale School of Public Health (YSPH) and six other partners to make up its new Pathogen Genomics Center of Excellence, one of five such centers recently launched by the U.S. Centers for Disease Control and Prevention. With $25 million in funding over five years, the center’s goal will be to improve technologies and coordinated processes for systematically monitoring infectious diseases and emerging variants, enabling the U.S. to better prevent and respond to outbreaks.